DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 04 · Volume 125 · April 2025 DOI: 10.1055/s-015-61419

Review Article

  • 291
    Böhm, Elsa Wilma; Buonfiglio, Francesco; Korb, Christina A.; Dauth, Alice; Pfeiffer, Norbert; Bręborowicz, Andrzej; Gericke, Adrian:

    Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion

    Image for article: Potential of Sulodexide in the Treatment of Diabetic Retinopathy and Retinal Vein Occlusion
  • Coagulation and Fibrinolysis

  • 308
    Taniguchi, Hayato; Abe, Takeru; Takeuchi, Ichiro; Ohshimo, Shinichiro; Shime, Nobuaki; Kushimoto, Shigeki; Hashimoto, Satoru; Takeda, Shinhiro; on behalf of the Japan ECMO Network:

    Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan

    Image for article: Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan
  • Cellular Haemostasis and Platelets

  • 317
  • 340
  • Invited Editorial Focus

  • 337
  • 376
  • New Technologies, Diagnostic Tools and Drugs

  • 352
    Geisen, Christof; Fleck, Erika; Schäfer, Stephan Martin Gastón; Walter, Carmen; Braeuninger, Susanne; Jensen, Jens Søndergaard; Sheridan, Douglas; Patki, Kiran; Armstrong, Róisín; Skogen, Bjørn; Behrens, Frank; Seifried, Erhard; Kjeldsen-Kragh, Jens; Kjær, Mette; Köhm, Michaela:

    A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention

    Image for article: A Phase 1b PK/PD Study to Demonstrate Antigen Elimination with RLYB212, A Monoclonal Anti-HPA-1a Antibody for FNAIT Prevention
  • Stroke, Systemic or Venous Thromboembolism

  • 364
    Glise Sandblad, Katarina; Svensson, Carl Johan; Svennerholm, Kristina; Philipson, Jacob; Pivodic, Aldina; Schulman, Sam; Tavoly, Mazdak:

    Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis

    Image for article: Time Trends and Excess Mortality Compared to Population Controls after a First-Time Pulmonary Embolism or Deep Vein Thrombosis
  • 379
  • 385
  • Trial Protocol Design Paper

  • 395
    Korompoki, Eleni; Heuschmann, Peter; Harvey, Kirsten H.; Fiessler, Cornelia; Malzahn, Uwe; Hügen, Klemens; Ullmann, Sabine; Todd, Gabriele Putz; Schuhmann, Carolin; Montaner, Joan; Sibon, Igor; Debette, Stephanie; Enzinger, Christian; Ropele, Stefan; Rücker, Viktoria; Haas, Kirsten; Harvey, Emily; Wolfe, Charles; Wang, Yanzhong; Nielsen, Peter B.; Caso, Valeria; Lip, Gregory Y. H.; Lane, Deirdre A.; Halse, Omid; Ringleb, Peter; Haefeli, Walter E.; Foerster, Kathrin I.; Wurmbach, Viktoria S.; Veltkamp, Roland; on behalf of PRESTIGE-AF investigators:

    Prevention of Stroke in Intracerebral Haemorrhage Survivors with Atrial Fibrillation: Rationale and Design for PRESTIGE-AF Trial